CD36 and atherosclerosis: Previous experiments have shown that disruption of the SRA1 or CD36 pathway partially inhibits the uptake of acetylated-LDL (Ac-LDL) or ox-LDL by macrophages while delaying the progression of atherosclerosis in hypercholesterolemic mice (11).